$BFYW
Better For You Wellness, Inc.

2023 Q3 Form 10-Q Financial Statement

#000157587223001169 Filed on July 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $1.800K $1.850K $2.410K
YoY Change -85.87% 58.55%
Cost Of Revenue $381.00 $930.00 $3.030K
YoY Change -89.08% -90.94% 315.07%
Gross Profit $1.423K $920.00 -$620.00
YoY Change -334.05% -67.38% -178.48%
Gross Profit Margin 79.06% 49.73% -25.73%
Selling, General & Admin $281.4K $705.0K $1.151M
YoY Change -22.08% -6.87% 110.53%
% of Gross Profit 19774.7% 76631.52%
Research & Development $0.00 $0.00
YoY Change
% of Gross Profit 0.0% 0.0%
Depreciation & Amortization $200.00 $190.00 $200.00
YoY Change 66.67% 0.0%
% of Gross Profit 14.05% 20.65%
Operating Expenses $462.1K $705.0K $1.151M
YoY Change -34.68% -6.87% 138.89%
Operating Profit -$460.7K -$704.1K -$1.152M
YoY Change -34.94% -6.64% 139.41%
Interest Expense -$25.51K -$43.80K -$55.94K
YoY Change -141.79% 20.43%
% of Operating Profit
Other Income/Expense, Net -$25.51K -$43.80K
YoY Change -67.72% 5.71%
Pretax Income -$486.2K -$747.9K -$1.208M
YoY Change -38.23% -45.53% 151.03%
Income Tax
% Of Pretax Income
Net Earnings -$486.2K -$747.9K -$1.208M
YoY Change -38.23% -45.53% 151.03%
Net Earnings / Revenue -27010.78% -40426.49% -50121.99%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 405.0M 404.2M 404.0M shares
Diluted Shares Outstanding 411.8M 404.1M

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.210K $17.78K $13.77K
YoY Change 16.73% 558.52% 42.84%
Cash & Equivalents $3.209K $17.78K $13.77K
Short-Term Investments
Other Short-Term Assets $10.02K $10.93K $18.49K
YoY Change -90.58% -86.0%
Inventory $910.00 $420.00 $979.00
Prepaid Expenses $10.02K $10.93K $18.49K
Receivables $2.259K $2.010K $1.460K
Other Receivables $29.32K $19.86K $0.00
Total Short-Term Assets $45.72K $50.99K $34.71K
YoY Change -60.24% 424.05% 260.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.159K $215.4K $1.547K
YoY Change -60.12% 35204.92% 111.92%
Goodwill $583.5K $583.5K $583.5K
YoY Change 1.04% -0.02%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $780.7K $798.8K $585.0K
YoY Change 34.51% 130857.38%
TOTAL ASSETS
Total Short-Term Assets $45.72K $50.99K $34.71K
Total Long-Term Assets $780.7K $798.8K $585.0K
Total Assets $826.4K $849.8K $619.7K
YoY Change 18.84% 8118.86% 6328.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $719.2K $564.8K $390.8K
YoY Change 7223.73% 249.02% 13.15%
Accrued Expenses $73.61K $72.91K
YoY Change 349.51%
Deferred Revenue
YoY Change
Short-Term Debt $913.5K $1.055M $887.8K
YoY Change 5.75% 69.75% 338.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.955M $2.173M $1.719M
YoY Change 72.83% 222.18% 357.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.220K
YoY Change
Other Long-Term Liabilities $122.4K $141.1K
YoY Change
Total Long-Term Liabilities $122.4K $141.1K $2.224K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.955M $2.173M $1.719M
Total Long-Term Liabilities $122.4K $141.1K $2.224K
Total Liabilities $2.078M $2.314M $1.722M
YoY Change 83.65% 243.1% 358.59%
SHAREHOLDERS EQUITY
Retained Earnings -$7.310M -$6.823M -$6.076M
YoY Change 121.86% 93.61% 247.49%
Common Stock $41.92K $40.41K $40.40K
YoY Change 8.83% 6.32% 8.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.251M -$1.464M -$1.102M
YoY Change
Total Liabilities & Shareholders Equity $826.4K $849.8K $619.7K
YoY Change 18.84% 8118.86% 6328.8%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$486.2K -$747.9K -$1.208M
YoY Change -38.23% -45.53% 151.03%
Depreciation, Depletion And Amortization $200.00 $190.00 $200.00
YoY Change 66.67% 0.0%
Cash From Operating Activities -$67.56K -$136.5K -$56.80K
YoY Change -75.73% -66.27% -60.64%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$6.090K
YoY Change
Cash From Investing Activities $0.00 $0.00 -$6.090K
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 53.00K 140.5K 73.50K
YoY Change -81.12% -64.67% -52.26%
NET CHANGE
Cash From Operating Activities -67.56K -136.5K -56.80K
Cash From Investing Activities 0.000 0.000 -6.090K
Cash From Financing Activities 53.00K 140.5K 73.50K
Net Change In Cash -14.56K 4.000K 10.61K
YoY Change -24366.67% -156.9% 10.06%
FREE CASH FLOW
Cash From Operating Activities -$67.56K -$136.5K -$56.80K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$67.56K -$136.5K -$56.80K
YoY Change -75.52% -66.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001852707
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-56262
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
Better For You Wellness, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2903933
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1349 East Broad Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43205
CY2023Q2 dei City Area Code
CityAreaCode
(614)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
368-9898
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
404990181
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17776
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13773
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2013
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1460
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10931
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18493
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
19857
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2023Q2 us-gaap Inventory Net
InventoryNet
416
CY2023Q1 us-gaap Inventory Net
InventoryNet
979
CY2023Q2 us-gaap Assets Current
AssetsCurrent
50993
CY2023Q1 us-gaap Assets Current
AssetsCurrent
34705
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1353
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1547
CY2023Q2 us-gaap Goodwill
Goodwill
583484
CY2023Q1 us-gaap Goodwill
Goodwill
583484
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
214003
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2023Q2 us-gaap Assets
Assets
849833
CY2023Q1 us-gaap Assets
Assets
619736
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
485933
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
391553
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
479919
CY2023Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
379759
CY2023Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
433500
CY2023Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
293000
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
78843
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
60243
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72911
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
620000
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
594804
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1876
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2103
CY2023Q2 bfyw Notes Payable Shopifys Capital
NotesPayableShopifysCapital
103
CY2023Q1 bfyw Notes Payable Shopifys Capital
NotesPayableShopifysCapital
121
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2173085
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1721583
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
141092
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-971072
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
43797
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
5063
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43797
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5063
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-747885
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
141092
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0
CY2023Q2 us-gaap Liabilities
Liabilities
2314177
CY2023Q1 us-gaap Liabilities
Liabilities
1721583
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
700000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
700000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
700000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
700000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
70
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
70
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
404114987
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
404114987
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
404014987
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
404014987
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
40413
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
40403
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5318659
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4933281
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6823486
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6075601
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1464344
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1101847
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
849833
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
619736
CY2023Q2 bfyw Merchandise Sales Amount
MerchandiseSalesAmount
1850
CY2022Q2 bfyw Merchandise Sales Amount
MerchandiseSalesAmount
306
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
932
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6069
CY2023Q2 us-gaap Gross Profit
GrossProfit
918
CY2022Q2 us-gaap Gross Profit
GrossProfit
-5763
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
392950
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
768313
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
312056
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
196996
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
705006
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
965309
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-704088
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-976135
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
404081291
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
404081291
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
363657794
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
363657794
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-365766
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
272735
CY2022Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
550000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
495578
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
13514
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
49686
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-976135
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39612
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1101847
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
950
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
384438
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-747885
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1464344
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-747885
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-976135
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
385388
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
768313
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25196
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12139
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
194
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
194
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
553
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-563
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6060
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7562
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0
CY2023Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
19857
CY2022Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
94380
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-213593
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-18600
CY2022Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-5063
CY2023Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
100160
CY2022Q2 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
100160
CY2023Q2 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-245
CY2022Q2 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-316
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-136497
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-298115
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6087
CY2023Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0
CY2022Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
2323
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8410
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
28320
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2022Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
279000
CY2023Q2 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
140500
CY2022Q2 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
0
CY2023Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0
CY2022Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-174
CY2023Q2 bfyw Expenses Contributed To Capital
ExpensesContributedToCapital
0
CY2022Q2 bfyw Expenses Contributed To Capital
ExpensesContributedToCapital
49686
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140500
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
300192
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4003
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6333
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13773
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9642
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17776
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3309
CY2023Q2 bfyw Common Stock Issued For Acquisition Value
CommonStockIssuedForAcquisitionValue
0
CY2022Q2 bfyw Common Stock Issued For Acquisition Value
CommonStockIssuedForAcquisitionValue
550000
CY2023Q2 us-gaap Stock Issued1
StockIssued1
0
CY2022Q2 us-gaap Stock Issued1
StockIssued1
17500
CY2023Q2 bfyw Discount On Notes Payable For Warrants
DiscountOnNotesPayableForWarrants
0
CY2022Q2 bfyw Discount On Notes Payable For Warrants
DiscountOnNotesPayableForWarrants
13514
CY2022Q3 bfyw Warrantcoverageraisedpercentage
Warrantcoverageraisedpercentage
0.49
CY2023Q2 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
17776
CY2023Q1 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
13773
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="font-family:Times New Roman,Times,serif;;display:inline;"><div style="font-weight:bold;display:inline;width:100%;"><div style="white-space:pre-line; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt; font-family: &quot;Times New Roman&quot;, Times, serif;;display:inline;"></div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;;display:inline;">Use of Estimates </div></div></div></div><div style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;margin-left: 0;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.11in; margin-right: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt;"><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;">The prepa<div style="display:inline;">rat</div>ion of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to<div style="display:inline;"> make th</div>e financial statements not misleading have been included. Actual results could differ from those estimates. </div><br/></div>
CY2023Q2 us-gaap Inventory Net
InventoryNet
416
CY2023Q1 us-gaap Inventory Net
InventoryNet
979
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023Q2 bfyw Valuation Allowance On Deferred Tax Assets
ValuationAllowanceOnDeferredTaxAssets
1
CY2023 bfyw Valuation Allowance On Deferred Tax Assets
ValuationAllowanceOnDeferredTaxAssets
1
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2023Q2 bfyw Treasury Rate
TreasuryRate
0.0381
CY2023Q2 bfyw Disclosure In Entirety Of Convertible Note
DisclosureInEntiretyOfConvertibleNote
Note 4 - Convertible Note Payable  <br/><div style="font-style: normal; font-variant: normal; font-stretch: normal; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0px 0px 0px 7.95pt; text-indent: 7.95pt; line-height: 12pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div></div><table cellpadding="0" cellspacing="0" style="font: 10pt &quot;Times New Roman&quot;, Times, serif; margin-top: 0px; margin-bottom: 0px; border-spacing: 0px;;text-indent: 0px;;width:100%;"><tr style="vertical-align: top"><td style="width: 0px; padding: 0pt;"><div style="display:inline;"></div></td><td style="width: 0.25in; padding: 0pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">(A)</div></td><td style="text-align: justify; padding: 0pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the "Note"). The closing of the Purchase Agreements occurred on April 12, 2022. The Note bears an original issue discount of $31,000, and interest of 12% per year and mature on April 12, 2023 (the "Maturity Date"). The Note is convertible into shares of the Company's common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements. </div></td></tr></table><div style="clear: both; max-height: 0px; text-indent: 0px;"></div><div style="font: 10pt / 12pt &quot;Times New Roman&quot;, Times, serif; margin: 0px 0px 0px 7.95pt; text-align: justify; text-indent: 7.95pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><table cellpadding="0" cellspacing="0" style="font: 10pt &quot;Times New Roman&quot;, Times, serif; margin-top: 0px; margin-bottom: 0px; border-spacing: 0px;;text-indent: 0px;;width:100%;"><tr style="vertical-align: top"><td style="width: 0px; padding: 0pt;"><div style="display:inline;"></div></td><td style="width: 0.25in; padding: 0pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">(B)</div></td><td style="text-align: justify; padding: 0pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">On June 7, 2022, the Company entered into a second Securities Purchase Agreement with Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”). The first Security Purchase Agreement with Mast Hill Fund, L.P. was entered On April 12, 2022. Pursuant to the June 7, 2022 Security Purchase Agreement, Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The closing of the Purchase Agreements occurred on June 7, 2022. The Note bears an original issue discount of $31,000, each bear interest of 12% per year and mature on June 7, 2023 (the “Maturity Date”). The Note is convertible into shares of the Company’s common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements.  </div></td></tr></table><div style="clear: both; max-height: 0px; text-indent: 0px;"></div><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; margin-right: 0px;"></div><div style="text-indent: 0px; margin-right: 0px; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 0px; margin-right: 0px; margin-bottom: 0px; margin-top: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;">Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing.</div></div><div style="text-indent: 0px; margin-right: 0px; margin-bottom: 0px; margin-top: 0px;"></div><div style="font-family: 'Times New Roman', 'serif';font-size: 10pt;margin-bottom: .001pt;margin-left: 0.11in;margin-top: 0;text-align: justify;text-indent: 0.11in;;font-weight: bold;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; line-height: 12pt;;display:inline;"> </div></div><div style="margin-top: 0px; margin-bottom: 0px; margin-right: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0px; margin-bottom: 0px; margin-right: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font: 10pt / 12pt &quot;Times New Roman&quot;, Times, serif; margin: 0px 0px 0px 0in; text-align: justify;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;"> In connection with the Purchase Agreements, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement within 90 days of the date of the Registration Rights Agreement covering the sale of the Commitment Shares and the shares of the Company’s common stock that may be issued to Mast Hill pursuant to the conversion of the Note. </div></div> <div style="font: 10pt / 12pt &quot;Times New Roman&quot;, Times, serif; margin: 0px; text-align: justify; text-indent: 0px;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font: 10pt / 12pt &quot;Times New Roman&quot;, Times, serif; margin: 0px 0px 0px 0in; text-align: justify;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">On July 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">April<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">12<div style="letter-spacing: 0px; top: 0px;;display:inline;">,<div style="letter-spacing: 0px; top: 0px;;display:inline;">20</div>22</div> to 180 calendar days to file the initial Registration Statement and 270 calendar days to have it declared effective. On October 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">April </div>12<div style="letter-spacing: 0px; top: 0px;;display:inline;">,2022</div> </div> <div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;"> until February 9, 2023, and to have the Registration Statement become effective on or before February 9, 2037. </div></div> <div style="font: 10pt / 12pt &quot;Times New Roman&quot;, Times, serif; margin: 0px 0px 0px 7.95pt; text-align: justify; text-indent: 7.95pt;"><div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-weight: normal; letter-spacing: 0px; top: 0px;;display:inline;">As of May 31, 2023, and February 28, 2023 the balances were $620,000 and $594,804 respectively. </div>The interest payable for the three-month period ending May 31,2023 and 2022 is $18600 and 5,063 respectively. The debt discount amortized for the three-month period ending May 31,2023 and 2022 is $25,196 and $12,139 respectively.
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
620000
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
594804
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-18600
CY2022Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-5063
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25196
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12139
CY2023Q2 bfyw Rental Payments
RentalPayments
6650
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2013
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1460
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2013
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1460
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2323
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2323
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
970
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
776
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1353
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1547
CY2023Q2 us-gaap Depreciation
Depreciation
194
CY2022Q2 us-gaap Depreciation
Depreciation
194
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
225887
CY2023Q2 bfyw Treasury Rate
TreasuryRate
0.0381
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
79800
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
79800
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
66500
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
226100
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12097
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
214003
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
72911
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
141092
CY2023Q2 bfyw Schedule Of Additional Information Pertaining To Our Leases
ScheduleOfAdditionalInformationPertainingToOurLeases
The following table set forth additional information pertaining to our leases:<div style="margin-top: 0px; margin-bottom: 0px; text-indent: 0px; line-height: 10pt; font-size: 10pt;"><br/></div> <table cellpadding="0" cellspacing="0" style="width: 100%; margin: 0in 0pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;margin-right : auto;"> <tr> <td style="width: 87%; padding: 0px 0pt 0.5pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">For the three months ending May 31,</div></div></div></div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgba(255, 255, 255, 0); border-bottom: 1pt solid windowtext; border-top: none; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; white-space: nowrap;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td colspan="1" style="border-top: none; border-image: initial; border-bottom: 1pt solid windowtext; width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; text-align: center;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">2023</div></div></div></div></div> </td> <td style="width: 1%; padding: 0in 0in 0.5pt; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; margin-left: 0in; text-indent: 0in; line-height: normal;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); width: 87%; padding: 0px 0pt; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">Cash paid for amounts included in the measurement of lease liabilities:</div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; border-bottom: none; border-top: 0px solid windowtext; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; white-space: nowrap;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="border-bottom: none; border-image: initial; background: rgb(204, 238, 255); width: 10%; border-top: 0px solid windowtext; padding: 0in; font-size: 10pt; white-space: nowrap; text-align: right; vertical-align: bottom;">—</td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom;"> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; margin-left: 0in; text-indent: 0in; line-height: normal;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); width: 87%; padding: 0px 0pt; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">Operating cash flows from operating leases</div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; white-space: nowrap;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">—</div></div></div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; margin-left: 0in; text-indent: 0in; line-height: normal;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgb(204, 238, 255); width: 87%; padding: 0px 0pt; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">Weighted average remaining lease term – operating leases</div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; white-space: nowrap;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom;"> <div style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">2.8 years</div></div></div></div> </td> <td style="background: rgb(204, 238, 255); width: 1%; padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom;"> <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; margin-left: 0in; text-indent: 0in; line-height: normal;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr> <td style="background: rgba(255, 255, 255, 0); width: 87%; padding: 0px 0pt; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">Weighted average discount rate – operating leases</div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 1%; padding: 0in; font-size: 10pt; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; white-space: nowrap;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> </div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; text-align: right; vertical-align: bottom;"> <div style="font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">3.81</div></div></div></div> </td> <td style="background: rgba(255, 255, 255, 0); width: 1%; padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom;"> <div style="margin-left: 0in; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; text-indent: 0in;;text-align:;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">%</div></div></div></div> </td> </tr> </table>
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0381
CY2023Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
433500
CY2023Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
293000
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
479919
CY2023Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
379759
CY2023Q2 bfyw Stock Purchase Warrant Liability Description
StockPurchaseWarrantLiabilityDescription
On April 18, 2022, we entered into a Standby Equity Commitment Agreement with MacRab LLC, a Florida limited liability company providing us with an option to sell up to $5,000,000 worth of our Common Stock, par value $0.0001, to MacRab LLC, in increments, over the period ending 24 months after the date that the Company’s registration statement is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. Additionally, we issued MacRab LLC a Common Stock purchase warrant for the purchase of 1,785,714 shares of our common stock as a commitment fee in connection with the execution of the Standby Equity Commitment Agreement. We also entered into a Registration Rights Agreement with the Investor requiring the Company to file a registration statement providing for the registration of the Common Stock issuable to MacRab LLC under the Standby Equity Commitment Agreement and their common stock purchase warrant, and the subsequent resale by MacRab LLC of such Common Stock.
CY2022Q2 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
22320
CY2023Q2 bfyw Non Cancelable Warrants Percentage
NonCancelableWarrantsPercentage
0.08
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
1.20
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
700000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
700000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
404114987
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
404114987
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
404014987
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
404014987
CY2023Q2 bfyw Purchase Commitment Shares
PurchaseCommitmentShares
4960000
CY2022Q2 bfyw Proceeds From Restricted Common Stock
ProceedsFromRestrictedCommonStock
40248
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
20000000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
14000000
CY2023Q2 bfyw Stock Option Description
StockOptionDescription
6,000,000 shares vest over the next year
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
25
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4853749
CY2023Q2 us-gaap Share Price
SharePrice
22
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.72
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0101
CY2022Q1 us-gaap Share Price
SharePrice
11
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.63
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0126
CY2023Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
384438
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
495577
CY2023Q2 bfyw Total Unamortized Stock Option Expense
TotalUnamortizedStockOptionExpense
230175
CY2023 bfyw Total Unamortized Stock Option Expense
TotalUnamortizedStockOptionExpense
614613
CY2022Q2 bfyw Fair Market Value
FairMarketValue
550000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
913
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
12995
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
13908
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
2365
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
2454
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
537
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
36
CY2022Q2 bfyw Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Gushy
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableGushy
35000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
40392
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-26484
CY2022Q2 us-gaap Business Acquisitions Purchase Price Allocation Subsequent Years Remaining Adjustments
BusinessAcquisitionsPurchasePriceAllocationSubsequentYearsRemainingAdjustments
-557000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
-583484
CY2023Q2 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
557000
CY2023Q2 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
583484

Files In Submission

Name View Source Status
0001575872-23-001169-index-headers.html Edgar Link pending
0001575872-23-001169-index.html Edgar Link pending
0001575872-23-001169.txt Edgar Link pending
0001575872-23-001169-xbrl.zip Edgar Link pending
bf021_ex31-1.htm Edgar Link pending
bf021_ex31-2.htm Edgar Link pending
bf021_ex32-1.htm Edgar Link pending
bf021_ex32-2.htm Edgar Link pending
bfyw-20230531.htm Edgar Link pending
bfyw-20230531.xsd Edgar Link pending
bfyw-20230531_cal.xml Edgar Link unprocessable
bfyw-20230531_def.xml Edgar Link unprocessable
bfyw-20230531_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bfyw-20230531_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfyw-20230531_lab.xml Edgar Link unprocessable